EP4 agonist KMN-159 induces osteogenesis in rodent and porcine dental models
Thomas A Owen, Phillip Rzeczycki, Natalia Da Ponte Leguizamon, Qiming Jin, Chandni Patel, Shanqiao Wei, Stephen D Barrett, Andre J van Wijnen, María Inés Morano · 2026
Read EP4 agonist KMN-159 induces osteogenesis in rodent and porcine dental models by Thomas A Owen, Phillip Rzeczycki, Natalia Da Ponte Leguizamon, Qiming Jin, Chandni Patel, Shanqiao Wei, Stephen D Barrett, Andre J van Wijnen, María Inés Morano (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13540226.txt.
Description
Thomas A Owen and eight colleagues test, in a 2026 study, a drug called KMN-159 that switches on the EP4 receptor and may help regrow dental bone. Bone loss around teeth and implants remains a practical problem in dentistry.
Human and rat marrow stem cells treated with the drug matured faster toward bone-forming cells and laid down more mineral in laboratory dishes and in bone scaffolds. In rats, treated tooth sockets and the bone around fresh implants gained volume. A pilot test in minipigs carrying human implants pointed the same way. The authors propose KMN-159 as a candidate for dental, facial, and broader skeletal repair work.
Catalog record
| CREATOR | Thomas A Owen, Phillip Rzeczycki, Natalia Da Ponte Leguizamon, Qiming Jin, Chandni Patel, Shanqiao Wei, Stephen D Barrett, Andre J van Wijnen, María Inés Morano |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74941 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |